Jun 21, 2024, 05:08
Enrique Grande: A Molecular-Directed Strategy with TP53 Mutation in small cell bladder cancer
Enrique Grande, Head of Oncology at MD Anderson Madrid Cancer Center, recently shared a post on X:
“Durable Objective Response to Lurbinectedin in Small Cell Bladder Cancer with TP53 Mutation:
A Molecular-Directed Strategy with TP53 Mutation.”
Additional information.
Source: Enrique Grande/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 21, 2025, 09:58
Feb 21, 2025, 09:54
Feb 21, 2025, 09:45
Feb 21, 2025, 09:35
Feb 21, 2025, 09:18
Feb 21, 2025, 09:07
Feb 21, 2025, 09:00
Feb 21, 2025, 08:19
Feb 21, 2025, 06:20